Current Pharmaceutical Design

Volume 7, Number 14, 1 September 2001

Links for this Journal

Book Reviews

Preface
pp. i-ii(1)
Author: Weyer, C.

Links for this article

Reviews

Rapid and Long-Acting Analogues as an Approach to Improve Insulin Therapy: An Evidence-Based Medicine Assessment
pp. 1303-1325(23)
Authors: Heise, T.; Heinemann, L.

Links for this article

Alternative Routes of Administration as an Approach to Improve Insulin Therapy: Update on Dermal, Oral, Nasal and Pulmonary Insulin Delivery
pp. 1327-1351(25)
Authors: Heinemann, L.; Pfutzner, A.; Heise, T.

Links for this article

Amylin Replacement With Pramlintide as an Adjunct to Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: A Physiological Approach Toward Improved Metabolic Control
pp. 1353-1373(21)
Authors: Weyer, C.; Maggs, D.G.; Young, A.A.; Kolterman, O.G.

Links for this article

Rapid Acting Insulinotropic Agents: Restoration of Early Insulin Secretion as a Physiologic Approach to Improve Glucose Control
pp. 1375-1397(23)
Authors: Pratley, R.E.; Foley, J.E.; Dunning, B.E.

Links for this article

Development of Glucagon-Like Peptide-1-Based Pharmaceuticals as Therapeutic Agents for the Treatment of Diabetes
pp. 1399-1412(14)
Author: Drucker, D.J.

Links for this article

Imidazoline Binding Sites in the Endocrine Pancreas: Can They Fulfil Their Potential as Targets for the Development of New Insulin Secretagogues?
pp. 1413-1431(19)
Authors: Morgan, N.G.; Chan, S.L.F.

Links for this article

Beta3 -Adrenoceptor Agonists as Anti-diabetic and Anti-obesity Drugs in Humans
pp. 1433-1449(17)
Authors: de Souza, C.J.; Burkey, B.F.

Links for this article

Pharmacological Approaches to Inhibit Endogenous Glucose Production as a Means of Anti-diabetic Therapy
pp. 1451-1474(24)
Authors: McCormack, J.G.; Westergaard, N.; Kristiansen, M.; Brand, C.L.; Lau, J.

Links for this article